salicylamide has been researched along with Carcinoma, Hepatocellular in 1 studies
salamide: a major impurity of hydrochlorothiazide; structure in first source
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MacDonald, CJ | 1 |
| Ciolino, HP | 1 |
| Yeh, GC | 1 |
1 other study available for salicylamide and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
The drug salicylamide is an antagonist of the aryl hydrocarbon receptor that inhibits signal transduction induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Topics: Carcinogens; Carcinoma, Hepatocellular; Cell Line, Tumor; Cytochrome P-450 Enzyme System; DNA Primer | 2004 |